secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2025-01-28T23:59:59+00:00
Accession:  0001104659-25-006732
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics files corporate presentation; no material new data disclosed
--------------------------------------------------------------------------------

- Company furnished a corporate presentation discussing its focus on targeting pathogenic oligomers for neurodegenerative diseases.
- Presentation dated January 2025; no specific financial results, pipeline updates, or guidance provided in the excerpt.
- Filing under Item 8.01 is a routine disclosure; no other material events reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465925006732/0001104659-25-006732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465925006732/tm254703d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-006732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer